Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schwartsmann

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Interferon alpha-2-beta enhances immunoscintigraphic localization of monoclonal antibody in malignant melanomaB J Marroni, E B Ludwig, M J Almeida, et al.
Reproduction in Domestic Animals = Zuchthygiene|November 11, 2008
The effects of sample size on the outcome of ovarian tissue cryopreservationM Ferreira, A Bos-Mikich, N Frantz, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 22, 2001
von Willebrand factor antigen levels in plasma of patients with malignant breast diseaseL M Röhsig, D C Damin, S D Stefani, et al.
American Journal of Clinical Oncology|April 25, 2001
Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic indexE Sprinz, A P Caldas, D R Mans, et al.
Tumori|July 1, 1996
Phase II study of pentosan polysulfate (PPS) in patients with AIDS-related Kaposi's sarcomaG Schwartsmann, E Sprinz, L Kalakun, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsH R Hendriks, S Langdon, D P Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2008
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patientsX Pivot, P Koralewski, J L Hidalgo, et al.
Breast Cancer Research and Treatment|August 1, 1997
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancerA M Murad, R C Guimaraes, W C Amorim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Essential drugs for cancer therapy: a World Health Organization consultationK Sikora, S Advani, V Koroltchouk, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 30, 2009
Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancerF C Jobim, N L Xavier, D M Uchoa, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Interferon alpha-2-beta enhances immunoscintigraphic localization of monoclonal antibody in malignant melanomaB J Marroni, E B Ludwig, M J Almeida, et al.
Reproduction in Domestic Animals = Zuchthygiene|November 11, 2008
The effects of sample size on the outcome of ovarian tissue cryopreservationM Ferreira, A Bos-Mikich, N Frantz, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 22, 2001
von Willebrand factor antigen levels in plasma of patients with malignant breast diseaseL M Röhsig, D C Damin, S D Stefani, et al.
American Journal of Clinical Oncology|April 25, 2001
Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic indexE Sprinz, A P Caldas, D R Mans, et al.
Tumori|July 1, 1996
Phase II study of pentosan polysulfate (PPS) in patients with AIDS-related Kaposi's sarcomaG Schwartsmann, E Sprinz, L Kalakun, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsH R Hendriks, S Langdon, D P Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2008
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patientsX Pivot, P Koralewski, J L Hidalgo, et al.
Breast Cancer Research and Treatment|August 1, 1997
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancerA M Murad, R C Guimaraes, W C Amorim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Essential drugs for cancer therapy: a World Health Organization consultationK Sikora, S Advani, V Koroltchouk, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 30, 2009
Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancerF C Jobim, N L Xavier, D M Uchoa, et al.
Pageof 9